Award

NIH Reporter #1R01HL181640-01A1

Mechanisms of Sex-specific responses to obstructive sleep apnea Therapies (MoST)

Recipient

New York University School of Medicine

Award Amount

$795,421.00

Ceiling

$795,421.00

Awarded

August 31, 2026

Identifier

1R01HL181640-01A1

NYU School of Medicine received NIH funding for a clinical trial studying whether men and women respond differently to obstructive sleep apnea treatments, particularly N-acetylcysteine and positive airway pressure.

Description

A randomized crossover clinical trial examining sex-specific responses to obstructive sleep apnea therapies, including positive airway pressure and N-acetylcysteine, and their effects on vascular function and cardiovascular risk.

View original record